Quest PharmaTech Inc. Stock Other OTC
Equities
QPTFF
CA74836M1068
Biotechnology & Medical Research
Financials (USD)
Sales 2023 | - | Sales 2024 | - | Capitalization | 4.23M |
---|---|---|---|---|---|
Net income 2023 | -7M | Net income 2024 | -3M | EV / Sales 2023 | - |
Net Debt 2023 | 625K | Net Debt 2024 | 283K | EV / Sales 2024 | - |
P/E ratio 2023 |
-1.61
x | P/E ratio 2024 |
-1.4
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 82.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 04-06-16 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 04-06-16 | |
J. Lievonen
CHM | Chairman | - | 21-07-04 |
Jeffrey Shon
BRD | Director/Board Member | - | 21-07-04 |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |